Active versus passive mechanisms in metastasis: do cancer cells crawl into vessels, or are they pushed?

Lancet Oncology

Volumn 8, Issue 5, 2007, Pages 444-448

  Bockhorn, Maximilian ^a   Jain, Rakesh K ^b   Munn, Lance L ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN; ANGIOSTATIN; BASIC FIBROBLAST GROWTH FACTOR; EPHRIN; MATRIX METALLOPROTEINASE; THROMBOSPONDIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD FLOW; BLOOD VESSEL; CANCER CELL; CANCER LOCALIZATION; CANCER SIZE; CELL ADHESION; CELL DESTRUCTION; CELL MIGRATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; ENZYME LOCALIZATION; EVIDENCE BASED MEDICINE; EXTRAVASATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HEMATOLOGIC MALIGNANCY; HUMAN; HYPOTHESIS; IMMUNE SYSTEM; LYMPH VESSEL; MALIGNANT NEOPLASTIC DISEASE; METASTASIS POTENTIAL; MOLECULAR MECHANICS; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHEAR STRESS; STROMA CELL; TRANSCRIPTION REGULATION; TUMOR VASCULARIZATION;

EID: 34247197835     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(07)70140-7     Document Type: Note

References (62)

1. Zetter B. Adhesion molecules in tumor metastasis. Semin Cancer Biol 4 (1993) 219-229
2. Fidler I. Critical determinants of metastasis. Semin Cancer Biol 12 (2002) 89-96
3. Ruoslahti E. Cell adhesion and tumor metastasis. Princess Takamatsu Symp 24 (1994) 99-105
4. Wong C., Song C., Grimes M., et al. Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol 161 (2002) 749-753
5. Butler T., and Gullino P. Quantitation of cell shedding into efferent blood of mammary adenocarcinoma. Cancer Res 35 (1975) 512-516
6. Liotta L., Saidel M., and Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 36 (1976) 889-894
7. Condeelis J., and Pollard J. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124 (2006) 263-266
8. Condeelis J., Wyckoff J., and Segall J. Imaging of cancer invasion and metastasis using green fluorescent protein. Eur J Cancer 36 (2000) 1671-1680
9. Fidler I. The relationship of embolic homogeneity, number, size and viability to the incidence of experimental metastasis. Eur J Cancer 9 (1973) 223-227
10. Fidler I., Yano S., Zhang R., Fujimaki T., and Bucana C. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3 (2002) 53-57
11. Hood J., and Cheresh D. Role of integrins in cell invasion and migration. Nat Rev Cancer 2 (2002) 91-100
12. Bernards R., and Weinberg R. A progression puzzle. Nature 418 (2002) 823
13. Ramaswamy S., Ross K., Lander E., and Golub T. A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (2003) 49-54
14. Shioda T., Munn L., Fenner M., Jain R., and Isselbacher K. Early events of metastasis in the microcirculation involve changes in gene expression of cancer cells. Tracking mRNA levels of metastasizing cancer cells in the chick embryo chorioallantoic membrane. Am J Pathol 150 (1997) 2099-2112
15. Freije J., Balbin M., Pendas A., Sanchez L., Puente X., and Lopez-Otin C. Matrix metalloproteinases and tumor progression. Adv Exp Med Biol 532 (2003) 91-107
16. Egeblad M., and Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2 (2002) 161-174
17. Moses M. The regulation of neovascularization of matrix metalloproteinases and their inhibitors. Stem Cells 15 (1997) 180-189
18. Kopfstein L., and Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell Mol Life Sci 63 (2006) 449-468
19. Ribatti D., Nico B., and Vacca A. Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 25 (2006) 4257-4266
20. Bockhorn M., Roberge S., Sousa C., Jain R., and Munn L. Differential gene expression in metastasizing cells shed from kidney tumors. Cancer Res 64 (2004) 2469-2473
21. Racila E., Euhus D., Weiss A., et al. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 95 (1998) 4589-4594
22. Larson C., Moreno J., Pienta K., et al. Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry 62 (2004) 46-53
23. Mehes G., Witt A., Kubista E., and Ambros P. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159 (2001) 17-20
24. Swartz M., Kristensen C., Melder R., et al. Cells shed from tumours show reduced clonogenicity, resistance to apoptosis, and in vivo tumorigenicity. Br J Cancer 81 (1999) 756-759
25. Chang Y., di Tomaso E., McDonald D., Jones R., Jain R., and Munn L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci USA 97 (2000) 14608-14613
26. Hashizume H., Baluk P., Morikawa S., et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156 (2000) 1363-1380
27. Helmlinger G., Netti P., Lichtenbeld H., Melder R., and Jain R. Solid stress inhibits the growth of multicellular tumor spheroids. Nat Biotechnol 15 (1997) 778-783
28. Padera T., Stoll B., Tooredman J., Capen D., di Tomaso E., and Jain R. Pathology: cancer cells compress intratumour vessels. Nature 427 (2004) 695
29. Cavallaro U., and Christofori G. Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 1552 (2001) 39-45
30. de Amicis F., Lanzino M., Kisslinger A., et al. Loss of proline-rich tyrosine kinase 2 function induces spreading and motility of epithelial prostate cells. J Cell Physiol 209 (2006) 74-80
31. Koike C., McKee T., Pluen A., et al. Solid stress facilitates spheroid formation: potential involvement of hyaluronan. Br J Cancer 86 (2002) 947-953
32. Raghunand N., Gatenby R., and Gillies R. Microenvironmental and cellular consequences of altered blood flow in tumours. Br J Radiol 76 Spec No 1 (2003) S11-S22
33. Cardone R., Casavola V., and Reshkin S. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat Rev Cancer 5 (2005) 786-795
34. Chambers A., MacDonald I., Schmidt E., Morris V., and Groom A. Clinical targets for anti-metastasis therapy. Adv Cancer Res 79 (2000) 91-121
35. Sugarbaker P. Metastatic inefficiency: the scientific basis for resection of liver metastases from colorectal cancer. J Surg Oncol 3 Suppl (1993) 158-160
36. Weiss L. Cancer cell traffic from the lungs to the liver: an example of metastatic inefficiency. Int J Cancer 25 (1980) 385-392
37. Carmeliet P., and Jain R. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
38. Jain R. Molecular regulation of vessel maturation. Nat Med 9 (2003) 685-693
39. Liotta L., Kleinerman J., and Saidel G. Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34 (1974) 997-1004
40. Mehes G., Witt A., Kubista E., and Ambros P. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 159 (2001) 17-20
41. Glinsky G. Apoptosis in metastatic cancer cells. Crit Rev Oncol Hematol 25 (1997) 175-186
42. Sarbia M., and Gabbert H. Modern pathology: prognostic parameters in squamous cell carcinoma of the esophagus. Recent Results Cancer Res 155 (2000) 15-27
43. Jain R. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307 (2005) 58-62
44. Tong R., Boucher Y., Kozin S., Winkler F., Hicklin D., and Jain R. Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64 (2004) 3731-3736
45. Saadi W., Wang S., Lin F., and Jeon N. A parallel-gradient microfluidic chamber for quantitative analysis of breast cancer cell chemotaxis. Biomed Microdevices 8 (2006) 109-118
46. Schneider I., and Haugh J. Mechanisms of gradient sensing and chemotaxis: conserved pathways, diverse regulation. Cell Cycle 5 (2006) 1130-1134
47. Wang S., Saadi W., Lin F., Minh-Canh Nguyen C., and Li Jeon N. Differential effects of EGF gradient profiles on MDA-MB-231 breast cancer cell chemotaxis. Exp Cell Res 300 (2004) 180-189
48. Bartolome R., Galvez B., Longo N., et al. Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res 64 (2004) 2534-2543
49. Entschladen F., Drell IV T., Lang K., Joseph J., and Zaenker K. Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters. Lancet Oncol 5 (2004) 254-258
50. Morikawa K., Walker S., Nakajima M., Pathak S., Jessup J., and Fidler I. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res 48 (1988) 6863-6871
51. Hart I. 'Seed and soil' revisited: mechanisms of site-specific metastasis. Cancer Metastasis Rev 1 (1982) 5-16
52. Fukumura D., Xavier R., Sugiura T., et al. Tumor induction of VEGF promoter activity in stromal cells. Cell 94 (1998) 715-725
53. Hewitt R., Powe D., Carter G., and Turner D. Desmoplasia and its relevance to colorectal tumour invasion. Int J Cancer 53 (1993) 62-69
54. Dvorak H. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315 (1986) 1650-1659
55. Nakagawa H., Liyanarachchi S., Davuluri R., et al. Role of cancer-associated stromal fibroblasts in metastatic colon cancer to the liver and their expression profiles. Oncogene 23 (2004) 7366-7377
56. Kitadai Y., Sasaki T., Kuwai T., et al. Expression of activated platelet-derived growth factor receptor in stromal cells of human colon carcinomas is associated with metastatic potential. Int J Cancer 119 (2006) 2567-2574
57. Hunter K. Allelic diversity in the host genetic background may be an important determinant in tumor metastatic dissemination. Cancer Lett 200 (2003) 97-105
58. Domann F., Rice J., Hendrix M., and Futscher B. Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer 85 (2000) 805-810
59. Pardal R., Clarke M., and Morrison S. Applying the principles of stem-cell biology to cancer. Nat Rev Cancer 3 (2003) 895-902
60. Widschwendter M., Fiegl H., Egle D., et al. Epigenetic stem cell signature in cancer. Nat Genet 39 (2007) 157-158
61. Setoguchi T., Taga T., and Kondo T. Cancer stem cells persist in many cancer cell lines. Cell Cycle 3 (2004) 414-415
62. Jain R., Tong R., and Munn L. Effect of vascular normalization by anti-angiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res (2007). published online March 15. DOI:10.1158/0008-5472.CAN-06-4102